Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic Parkinson's disease: One year follow-up

Journal of Neural Transmission

Volumn 106, Issue 7-8, 1999, Pages 693-709

  Pinter, M M ^a   Alesch, F ^b   Murg, M ^a   Seiwald, M ^c   Helscher, R J ^a   Binder, H ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Deep brain stimulation; Parkinson's disease; Subthalamic nucleus

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; PERGOLIDE; SELEGILINE;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DYSKINESIA; ELECTRODE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; MOTOR PERFORMANCE; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SUBCUTANEOUS DRUG ADMINISTRATION; SUBTHALAMIC NUCLEUS; SUDDEN DEATH; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTIPARKINSON AGENTS; DYSKINESIAS; ELECTRIC STIMULATION THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC; SUBTHALAMIC NUCLEUS;

EID: 0032813971     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050190     Document Type: Article

References (39)

1. Alesch F, Pinter MM, Helscher RJ, et al. (1995) Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir 136:75-81
2. Aziz TZ, Peggs D, Argarwal E, Sambrook MA, Crossmann AR (1992) Subthalamic nucleotomy alleviates parkinsionsm in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primates. Br J Neurosurg 6: 575-582
3. Bakay RAE, DeLong MR, Vitek JL (1992) Posteroventral pallidotomy for Parkinson's disease. J Neurosurg 77: 487-488
4. Baron MS, Vitek JL, Bakay RAE, et al. (1996) Treatment of advanced Parkinson's disease by posterior Gpi pallidotomy: 1-year results of a pilot study. Ann Neurol 40: 355-366
5. Benabid AL, Pollak P, Gross C, et al. (1994) Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 62: 76-84
6. Benazzouz A, Gross C, Feger J, et al. (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 5: 382-389
7. Benazzouz A, Boraud T, Feger J, et al. (1996) Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-dopa treatment. Mov Disord 11 (6): 627-632
8. Bergmann H, Wichmann T, De Long MR (1990) Reversal of experimental parkinsonism by lesion of the subthalamic nucleus. Science 249: 1436-1438
9. Bravi D, Mouradian MM, Roberts JW, et al. (1993) End-of-dose dystonia in Parkinson's disease. Neurology 43: 2130-2131
10. Brown RG, Jahanshahi M, Limousin P, et al. (1996) Effects of subthalamic nucleus (STN) stimulation on motor functions in Parkinson's disease (PD). II. Behavioural measures of simple and complex hand-arm movement. Soc Neurosci Abstr 22 (1): 416
11. Carpenter MB, Whittier JR, Mettler FA (1950) Analysis of choreoid hyperkinesia in the rhesus monkey, surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus of Luys. J Comp Neurol 92: 413-425
12. Fahn S, Elton R, Members of the UPDRS Development Comitee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson's disease. Mac Millian Helathcare Information, Florham Park, pp 153-163
13. Fazzini E, Dogali M, Sterio D, et al. (1997) Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy. Neurology 48: 1273-1277
14. Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51: 745-752
15. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442
16. Hughes A, Lees AJ, Stern GM (1990) Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet 336: 32-34
17. Krack P, Limousin P, Benabid AL, Pollak P (1997) Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet 350: 1676
18. Krack P, Pollak P, Limousin P, et al. (1998) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 121: 451-457
19. Laitinen LV (1994) Ventroposterolateral pallidotomy. Stereotact Funct Neurosurg 62: 41-52
20. Laitinen LV, Bergenheim T, Hariz MI (1992) Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 76: 53-61
21. Lee CS, Scgulzer M, Mak E, et al. (1995) Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis. Neurol 45: 435-439
22. Limousin P, Pollak P, Benazzouz A, et al. (1995a) Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord 10: 672-674
23. Limousin P, Pollak P, Benazzouz A, et al. (1995b) Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 354: 91-95
24. Limousin P, Pollak P, Hoffmann D, et al. (1996) Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord 11:231-235
25. Limousin P, Greene J, Pollak P, et al. (1997) Changes in cerebral activity pattern due to subthalmic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 42: 283-291
26. Lindvall O, Rehncrona S, Brundin P, et al. (1989) Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-months follow-up. Arch Neurol 46: 615-631
27. Lozano AM, Lang AE, Galvez-Jimenez N, et al. (1995) Effect of GPI pallidotomy on motor function in Parkinson's disease. Lancet 346: 1383-1387
28. Marsden CD, Parkes JD (1976) "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 7: 292-296
29. Nutt JG, Holford NGH (1996) The response to levodopa in Parkinson's disease: imposing pharmacological law and order. Ann Neurol 39: 561-573
30. Pinter MM, Helscher RJ (1993) Apomorphinapplikation bei Morbus Parkinson Patienten mit therapierefraktäreen Oszillationen. Neuropsychiatrie 7(3): 120-124
31. Richards M, Marder K, Cote L, Mayeux R (1994) Interrater reliability of the Unified Parkinson's disease rating scale motor examination. Mov Disord 9: 89-91
32. Rossini PM, Scerrati M, Pauri F, et al. (1997) Neurophysiological evaluation of Parkinson's disease patients with implanted electrodes in subthalamic nuclei. Electroencephalogr Clin Neurophysiol Abstr 103: 131
33. Rothwell JC (1997) Analysis of central motor control: pathophysiology. Electroencephalogr Clin Neurophysiol Abstr 103: 48
34. Schaltenbrand G, Wahren W (1977) Atlas for stereotaxy of the human brain. G Thieme, Stuttgart
35. Stibe CMH, Lees AJ, Kempster PA, Stern GM (1988) Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet i: 403-406
36. Verhagen Metman L, Locatelli ER, Bravi D, et al. (1997) Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications. Neurology 48:369-372
37. Wichmann T, Bergmann H, DeLong MR (1994) The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallicum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 72(2): 521-530
38. Williams J (1980) Diagnostic and statistical manual of mental disorders, 3rd ed. American Psychiatric Association, Washington DC
39. Wu RM, Chiu HC, Wang M, Chen RC (1993) Risk factors on the occurrence of response fluctuations and dyskinesias in Parkinson's disease. J Neural Transm [P-D Sect] 5: 127-133